Man Group
HZNP

Man Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Man Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,025,550
Closed -$110M – 54
2023
Q2 		$105M Buy
+1,025,550
New +$108M 0.33% 51
2023
Q1 		– Sell
-651,030
Closed -$72M – 64
2022
Q4 		$74.1M Buy
651,030
+283,139
+77% +$23.5M 0.27% 78
2022
Q3 		$22.8M Buy
+367,891
New +$25.7M 0.11% 232
2022
Q2 		– Sell
-9,409
Closed -$891K – 576
2022
Q1 		$990K Sell
9,409
-40,374
-81% -$3.93M ﹤0.01% 1374
2021
Q4 		$5.37M Buy
49,783
+41,527
+503% +$4.53M 0.02% 850
2021
Q3 		$905K Sell
8,256
-22,411
-73% -$2.33M ﹤0.01% 1361
2021
Q2 		$2.87M Sell
30,667
-4,388
-13% -$404K 0.01% 1115
2021
Q1 		$3.23M Buy
35,055
+1,188
+4% +$100K 0.01% 908
2020
Q4 		$2.48M Sell
33,867
-32,150
-49% -$2.39M 0.01% 1121
2020
Q3 		$5.13M Buy
66,017
+58,281
+753% +$4.01M 0.02% 801
2020
Q2 		$430K Sell
7,736
-116,598
-94% -$4.99M ﹤0.01% 1484
2020
Q1 		$3.68M Sell
124,334
-135,003
-52% -$4.57M 0.02% 621
2019
Q4 		$9.39M Buy
259,337
+61,663
+31% +$1.89M 0.03% 719
2019
Q3 		$5.38M Sell
197,674
-24,095
-11% -$623K 0.02% 833
2019
Q2 		$5.34M Buy
221,769
+80,216
+57% +$2.03M 0.02% 921
2019
Q1 		$3.74M Sell
141,553
-58,293
-29% -$1.38M 0.01% 1061
2018
Q4 		$3.9M Sell
199,846
-94,919
-32% -$1.86M 0.02% 892
2018
Q3 		$5.77M Buy
294,765
+96,128
+48% +$1.83M 0.02% 910
2018
Q2 		$3.29M Sell
198,637
-114,897
-37% -$1.75M 0.01% 1149
2018
Q1 		$4.45M Buy
+313,534
New +$4.63M 0.02% 916

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Man Group's HZNP Position: Q3 2023 in Review

Man Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 1,025,550 shares — an estimated $110M sold.

Man Group first reported a position in HZNP in Q1 2018 and held it in 20 quarters. The position peaked at $105M in Q2 2023. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

  • Man Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Man Group sold 1,025,550 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $110M.
  • Man Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2018 and held it in 20 quarters.
  • Man Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $105M in Q2 2023.
  • 485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on Man Group's 13F filing for Q3 2023, filed 14 Nov 2023.